drugset / Trial / NCT06235125
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Phase 1
Recruiting
10 enrolled
Ann & Robert H Lurie Children's Hospital of Chicago
On Target Laboratories, LLC · collab
NaSingle-groupOpen-labelDiagnostic
Summary
Pediatric subjects aged 6-17 with biopsy confirmed cancer and imaging findings suspicious for pulmonary metastatic disease scheduled to undergo pulmonary metastasectomy via and open or minimally invasive approach.
Timeline
- Start
- 2024-04-08
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | pafolacianine | Diagnostic / imaging agent | 0.025 mg/kg | Intravenous |